USSTOCK.TODAY
Regular Market
Log in Sign up

Syndax Pharmaceuticals Reports $83 million in Total Revenue for Q3

The Motley Fool +1 · ·by G4L

SNDX
SNDX Syndax Pharmaceuticals Inc
$9.49 -0.63%
View chart & analysis →
  1. 1Syndax recorded an 82% year-over-year increase in total revenue for the third quarter.
  2. 2Syndax Revuforj net sales reached $61 million in the third quarter.
  3. 3As of the end of the third quarter, Syndax holds more than $551 million in cash, cash equivalents, and investments.

So what's the key point?

Syndax Pharmaceuticals' third-quarter revenue grew by 82% compared to last year. The company also holds more than $551 million in cash.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Syndax Pharmaceuticals beats Q3 revenue expectations with $83.3 million Earnings Whispers · Nov 3BioMarin Pharma Exceeds $1 billion in Quarterly Revenue for the First Time The Motley Fool +1 · Nov 3Apple achieves record performance with $114.5 billion in September quarter revenue The Motley Fool +1 · Nov 3
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news